Showing 1 - 5 results of 5 for search 'Lee JM', query time: 0.02s Refine Results
  1. 1
    Prediction of emergence agitation using withdrawal reaction following rocuronium injection in preschool-aged patients undergoing inguinal herniorrhaphy: a preliminary exploratory observational trial

    Prediction of emergence agitation using withdrawal reaction following rocuronium injection in preschool-aged patients undergoing inguinal herniorrhaphy: a preliminary exploratory o... by Kim DH, Roh GU, Lee YB, Choi CI, Lee JM, Chae YJ

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Correlations Between Coronary Artery Disease, Coronary Artery Calcium Score, and Lipoprotein(a) Level in Korea

    Correlations Between Coronary Artery Disease, Coronary Artery Calcium Score, and Lipoprotein(a) Level in Korea by Kim J, Choi SW, Lee YS, Lee JM, Chung H, Woo JS, Kim WS, Choi YY, Kim W

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study)

    Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-B... by Chung WB, Ihm SH, Jang SW, Her SH, Park CS, Lee JM, Chang K, Jeon DS, Yoo KD, Seung KB

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson’s disease, in healthy volunteers

    A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson’s d... by Shin W, Lim KS, Kim MK, Kim HS, Hong J, Jhee S, Kim J, Yoo S, Chung YT, Lee JM, Cho DY

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo

    PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo by Chiang KC, Chen HY, Hsu SY, Pang JHS, Wang SY, Hsu JT, Yeh TS, Chen LW, Kuo SF, Sun CC, Lee JM, Yeh CN, Juang HH

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: